Tendencias en la hospitalización psiquiátrica por alcohol y drogas en Castilla y León entre 2005 y 2015

  1. Carlos Llanes-Álvarez 1
  2. Jesús María Andrés-de Llano 2
  3. Ana I. Álvarez-Navares 3
  4. M. Teresa Pastor-Hidalgo 4
  5. Carlos Roncero 5
  6. Manuel A. Franco-Martín 6
  1. 1 Complejo Asistencial de Zamora. Instituto de Investigación Biomédica de Salamanca.
  2. 2 Complejo Asistencial Universitario de Palencia. Universidad de Valladolid.
  3. 3 Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca
  4. 4 Hospital Virgen de la Concha
    info

    Hospital Virgen de la Concha

    Zamora, España

    ROR https://ror.org/02bhk3j29

  5. 5 Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca. Universidad de Salamanca.
  6. 6 Complejo Asistencial de Zamora. Instituto de Investigación Biomédica de Salamanca. Universidad de Salamanca.
Show affiliations +
Journal:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Year of publication: 2022

Volume: 34

Issue: 3

Pages: 189-196

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Adicciones: Revista de socidrogalcohol

Abstract

It has been estimated that alcohol, tobacco, and illicit drugs were re - sponsible for more than 10 million deaths worldwide in 2016, and there are many opportunities for improvement. Regarding innovative data analysis, advances have been made in the extraction of informa - tion from administrative databases for analytics purposes. We studied trends in hospitalization rates for alcohol and drug abuse over eleven years with Joinpoint Trend Analysis software. This is a descriptive study of cross-associations in 3,758 hospital admissions of patients admitted with a main diagnosis of alcohol and drug abuse or dependence in psychiatry units of public health centres of Castilla y León (Spain) between 2005 and 2015. Hospitalization trends for alcohol and drug related conditions declined over the eleven-year period. Separately, there was a statistically significant decrease in alcohol and cocaine related conditions, but a strong upward trend in cannabis related conditions between 2013 and 2015. Alcohol was the main cause of admission to psychiatric units with a diagnosis of addiction. In the 11 years researched, there was a progressive and constant reduction in admissions for substance use except for cannabis. The innovative statistical methodology has already proven to be useful for identifying trends and changes in different pathologies over time.

Bibliographic References

  • Anderson, P., Gual, A. y Rehm, J. (2018). Reducing the health risks derived from exposure to addictive substances. Current Opinion in Psychiatry, 31, 333-341. doi:10.1097/YCO.0000000000000432.
  • Castiglioni, S., Borsotti, A., Senta, I. y Zuccato, E. (2015). Wastewater analysis to monitor spatial and temporal patterns of use of two synthetic recreational drugs, ketamine and mephedrone, in Italy. Environmental Science & Technology, 49, 5563-5570. doi:10.1021/es5060429.
  • Censo de población. Instituto Nacional de Estadística. Castilla y León [citado16 Mar 2017]. Recuperado de http://www.estadistica.jcyl.es/web/jcyl/Estadistica/es/Plantilla100/1284300554709/_/_/.
  • CIE-9-MC. Manual de codificación. Información y Estadísticas Sanitarias (2011). Ministerio de Sanidad, Política Social e Igualdad.
  • Comunidad de Madrid (2017). Informe sobre evolución de los ingresos hospitalarios por abuso o dependencia de sustancias psicoactivas. CMBD 2003-2015. Consejería de sanidad. Dirección General de Salud Pública, Subdirección General de Actuación en Adicciones. Flash Eurobarometer 330(2011). The Gallup Organization. Youth Attitudes on Drug: Analytical Report. Comisión Europea. Recuperado de https://ec.europa.eu/commfrontoffice/publicopinion/flash/fl_330_en.pdf.
  • Flash Eurobarometer 401 (2014). TNS political y social. Young people and drugs. Comisión Europea. Recuperado de https://ec.europa.eu/commfrontoffice/publicopinion/flash/fl_401_en.pdf.
  • GBD 2013 Risk Factors Collaborators. (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 2287-2323. doi:10.1016/S0140-6736(15)00128-2.
  • GBD 2016 Alcohol and Drug Use Collaborators. (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. Psychiatry, 5, 987-1012. doi:10.1016/S2215-0366(18)30337-7.
  • Gfroerer, J. C., Adams, E. H. y Moien, M. (1988). Drug abuse discharges from non-federal short-stay hospitals. American Journal of Public Health, 78, 1559-1562.
  • Hammarlund, R., Crapanzano, K., Luce, L., Mulligan, L. y Ward, K. (2018). Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Substance Abuse and Rehabilitation, 9, 115-136. doi:10.2147/SAR.S183256.
  • Joinpoint Trend Analysis Software provided by US National Cancer Institute. Surveillance Research Program. Recuperado de https://surveillance.cancer.gov/joinpoint/.
  • Junta de Castilla y León (2010). VI Plan Regional sobre Drogas de Castilla y León (2009-2013). Consejería de Familia e Igualdad de Oportunidades. Comisionado Regional para la Droga; Valladolid. Recuperado de www.jcyl.es/web/jcyl/Familia/es/Plantilla100DetalleFeed/1246988963464/Publicacion/1284402754415/Redaccion.
  • Kim, H. J., Fay, M. P., Feuer, E. J. y Midthune, D. N. (2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19, 335-351.
  • Leos-Toro, C., Rynard, V., Murnaghan, D., MacDonald, J. A. y Hammond, D. (2019). Trends in cannabis use over time among Canadian youth: 2004-2014. Preventive Medicine, 118, 30-37. doi:10.1016/j.ypmed.2018.10.002.
  • Lievens, D., Vander Laenen, F. y Christiaens, J. (2014). Public spending for illegal drug and alcohol treatment in hospitals: An EU cross-country comparison. Substance Abuse Treatment, Prevention, and Policy, 9, 26. doi:10.1186/1747-597X-9-26.
  • López Corbalán, J. C., Seguí Ripoll, J. M., Romero Escobar H., Luna Ruiz-Cabello, A. y Luna Maldonado, A. (2014). Detección del cannabinoide sintético JWH210 en la Comunidad Valenciana. Adicciones, 26, 187-188.
  • Mattick, R. P., Breen, C., Kimber, J. y Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Database of Systematic Reviews, 3, CD002209. doi:10.1002/14651858.CD002209.pub2.
  • Meléndez Frigola, C., Arroyo Borrell, E. y Saez, M. (2016). Data Analysis of Subacute Patients with Registered Information in the Minimum Basic Data Set for Social-Healthcare (CMBD-RSS), Spain. Revista Española de Salud Pública, 90, e1-e7.
  • Miquel, L., Manthey, J., Rehm, J., Vela, E., Bustins, M., Segura, L.,… Gual, A. (2018b). Risky alcohol use: The impact on health service use. European Addiction Research, 24, 234–244. doi:10.1159/000493884.
  • Miquel, L., Rehm, J., Shield, K. D., Vela, E., Bustins, M., Segura, L.,… Gual, A. (2018a). Alcohol, tobacco and health care costs: A population-wide cohort study (n = 606 947 patients) of current drinkers based on medical and administrative health records from Catalonia. European Journal of Public Health, 28, 674–680. doi:10.1093/eurpub/ckx236.
  • Mur Sierra, A. y Ortigosa Gómez, S. (2014). Is it possible a new heroin consumption epidemic in Spain? Medicina Clinica, 143, 398–400. doi:10.1016/j.medcli.2014.06.004.
  • Nosyk, B., Wood, E. y Kerr, T. (2015). The rise of marijuana and the fall of cocaine in the United States: For better, for worse? Addiction, 110, 5, 737-738. doi:10.1111/add.12738.
  • Observatorio Europeo de las Drogas y las Toxicomanías (2018). Informe Drogas España 2018. Madrid: Delegación del Gobierno para el Plan Nacional sobre Drogas. Recuperado de http://www.pnsd.mscbs.gob.es/profesionales/sistemasInformacion/internacional/pdf/InformeDrogasEspana2018_CDR2018Espanol.pdf.
  • Observatorio Europeo de las Drogas y las Toxicomanías (2017). Informe Europeo sobre Drogas: Tendencias y Novedades. Oficina de Publicaciones de la Unión Europea, Luxemburgo. doi:10.2810/96795.
  • Oficina de las Naciones Unidas contra la Droga y el Delito (2015). Informe Mundial sobre las Drogas. Recuperado de https://www.unodc.org/documents/wdr2015/WDR15_ExSum_S.pdf.
  • Oficina de las Naciones Unidas contra la Droga y el Delito (2017). Informe Mundial sobre las Drogas (ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3, publicación de las Naciones Unidas, núm. de venta S.17.XI.6).
  • Rehm, J., Anderson, P., Barry, J., Dimitrov, P., Elekes, Z., Feijão, F.,… Gmel, G. (2015). Prevalence of and potential influencing factors for alcohol dependence in Europe. European Addiction Research, 21, 6-18. doi:10.1159/000365284.
  • Ruch, D. A., Sheftall, A. H., Schlagbaum, P., Rausch, J., Campo, J. V. y Bridge, J. A. (2019). Trends in suicide among youth aged 10 to 19 years in the United States, 1975 to 2016. JAMA Network Open, 2, e193886–e193886. doi:10.1001/jamanetworkopen.2019.3886.
  • Russ, T. C., Woelbert, E., Davis, K. A. S., Hafferty, J. D., Ibrahim, Z., Inkster, B.,… Stewart, R. MQ Data Science group. (2019). How data science can advance mental health research. Nature Human Behaviour, 3, 24-32. doi:10.1038/s41562-018-0470-9.
  • Schoepf, D. y Heun, R. (2015). Alcohol dependence and physical comorbidity: Increased prevalence but reduced relevance of individual comorbidities for hospital-based mortality during a 12.5-year observation period in general hospital admissions in urban North-West England. European Psychiatry, 30, 459-468. doi:10.1016/j.eurpsy.2015.03.001.
  • Smith, D. E. (2017). Medicalizing the opioid epidemic in the U.S. in the era of health care reform. Journal of Psychoactive Drugs, 49, 95-101. doi:10.1080/02791072.2017.1295334.
Data source: Dialnet